ANIP
What one share of Ani Pharmaceuticals holds
Pharmaceutical Preparations
ANI Pharmaceuticals is a diversified bio-pharmaceutical company. The Company's mission is “Serving Patients, Improving Lives” by developing, manufacturing, and commercializing therapeutics through its Rare Disease, Generics, and Brands businesses.
Ani Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $44.41 |
|---|---|
| Profit | $4.47 |
| Capex (buildings and equipment) | $0.75 |
| Free cash flow | $7.85 |
| Dividends | $0.02 |
| Cash and investments | $17.02 |
| Debt | $14.25 |
| Book value | $28.23 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $11.11 | $0.34 | $0.39 | $1.98 | — | $14.82 |
| 2017 | $15.31 | −$0.09 | $0.90 | $2.52 | — | $15.13 |
| 2018 | $17.12 | $1.30 | $0.49 | $5.21 | — | $16.89 |
| 2019 | $17.16 | $0.50 | $0.55 | $3.24 | — | $17.97 |
| 2020 | $17.43 | −$1.88 | $0.51 | $0.76 | — | $16.36 |
| 2021 | $17.16 | −$3.40 | $0.20 | $0.06 | — | $26.51 |
| 2022 | $19.46 | −$3.05 | $0.55 | −$2.46 | — | $19.29 |
| 2023 | $26.76 | $0.85 | $0.49 | $6.05 | — | $24.04 |
| 2024 | $31.80 | −$1.04 | $0.84 | $2.47 | — | $19.12 |
| 2025 | $41.61 | $3.32 | $0.65 | $8.07 | — | $24.04 |